Käännöksiä ei löytynyt valitulle kohdekielelle.
An antiangiogenic used to treat wet age-related macular degeneration.
Pegaptanib sodium – Macugen – Https://www.drugs.com/monograph/macugen.html – A607057 – Intravitreal injection – S01LA03 (WHO) – ℞-only – 10 days – RNA, ((2'-deoxy-2'-fluoro)C-Gm-Gm-A-A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-Am-Gm-(2'-deoxy-2'-fluoro)U-Gm-Am-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Gm-(3'→3')-dT), 5'-ester with α,α'-[4,12-dioxo-6[[[5-(phosphoonoxy)pentyl]amino]carbonyl]-3,13-dioxa-5,11-diaza-1,15-pentadecanediyl]bis[ω-methoxypoly(oxy-1,2-ethanediyl)], sodium salt – 222716-86-1 – DB04895 – None – 2H1PA8H1EN – DTXSID40944934 – C294H342F13N107Na28O188P28[C2H4O](m+n) (m+n≈900) – ~50 kg/mol.